As of May 18th, 2017, based on data on file with Ulthera, Inc, a division of Merz Pharma, it is reported that over 1 million patient treatments have been performed worldwide and over 3,700 Ulthera® Systems are in use globally. Merz warns against counterfeit Ulthera® Systems and fake Ultherapy® treatments Merz Pharma Group, the parent company of Ulthera, Inc., is issuing an alert to consumers of potential illegal promotions of the non-invasive skin lifting Ultherapy® treatment.